DONATE TODAY
To Increase Patient Access

December 5, 2022

PROSPECT Clinical Trial

Hope for Primary Central Nervous System Lymphoma (PCNSL)

PROSPECT Logo

Current treatment options for primary CNS lymphoma (PCNSL) are limited, and there are no medications approved specifically for the treatment of PCNSL in the United States. New treatment options are needed to improve the prognosis for those with PCNSL. 

The PROSPECT study is a clinical trial to evaluate an investigational oral medicine called tirabrutinib* in patients with PCNSL. About 112 participants will be enrolled in the Phase II (PROSPECT) study in the United States.

ANSWER A FEW QUESTIONS TO SEE IF YOU MAY BE ABLE TO PARTICIPATE!

Dark green block

Question #1:

Are you at least 18 years of age?

Question #2:

Have you been diagnosed with Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)?

By choosing to volunteer, you can help make a difference for thousands of others diagnosed with PCNSL.

*Tirabrutinib has been approved and is currently marketed in Japan for R/R PCNSL patients.


Get The New EBCI App

We know how important it is to find the information you are looking for when navigating a Brain Tumor diagnosis for yourself or a loved one. This app has the latest information on:

  • Clinical trials
  • Patient resources
  • Research

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
Our Case For Change
EBCI In The News
Patient Support Services
Patient Resource Center
VOLUNTEER WITH EBCI
GET IN TOUCH
corporate partners
upcoming events
resources
About us
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram